CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Artemis Therapeutics, Inc.  (INKS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

INKS's Operating Income Growth by Quarter and Year

Artemis Therapeutics,'s Operating Income results by quarter and year




INKS Operating Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 0.06 0.61 0.30
III Quarter September - 0.20 0.23 0.02
II Quarter June - 0.21 0.02 -0.02
I Quarter March -0.02 0.30 0.19 -0.04
FY   -0.02 0.77 1.05 0.26



INKS Operating Income first quarter 2019 Y/Y Growth Comment
Artemis Therapeutics, Inc. in the first quarter recorded Operating Loss of $ -0.02 millions.

Looking into first quarter results within Biotechnology & Drugs industry 13 other companies have achieved higher Operating Income growth. While Artemis Therapeutics, Inc.' s Operating Income no change of % ranks overall at the positon no. 1935 in the first quarter.

Explain Operating Income growth


INKS Operating Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - -90.16 % 103.33 % -
III Quarter September - -13.04 % 1050 % -
II Quarter June - 950 % - -
I Quarter March - 57.89 % - -
FY   - -26.67 % 303.85 % -

Financial Statements
Artemis Therapeutics,'s first quarter 2019 Operating Income $ -0.02 millions INKS's Income Statement
Artemis Therapeutics,'s first quarter 2018 Operating Income $ 0.30 millions Quarterly INKS's Income Statement
New: More INKS's historic Operating Income Growth >>


INKS Operating Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - -70 % 165.22 % 1400 %
III Quarter September - -4.76 % 1050 % -
II Quarter June - -30 % -89.47 % -
I Quarter March - -50.82 % -36.67 % -
FY (Year on Year)   - -26.67 % 303.85 % -




Operating Income first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #14
Healthcare Sector #122
Overall #1935

Operating Income Y/Y Growth Statistics
High Average Low
10.68 % -12.15 % -41.45 %
(Dec. 30, 2014)   (Mar 31 2019)
Operating Income first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #14
Healthcare Sector #122
Overall #1935
Operating Income Y/Y Growth Statistics
High Average Low
10.68 % -12.15 % -41.45 %
(Dec. 30, 2014)   (Mar 31 2019)

Operating Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Artemis Therapeutics,'s Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


INKS's I. Quarter Q/Q Operating Income Comment
Recent accomplishment of -0.02 millions by Artemis Therapeutics, Inc. look even more unfavourable compare to the Operating Loss 0.06 millions in the previous quarter.

Within Biotechnology & Drugs industry Artemis Therapeutics, Inc. achieved highest sequential Operating Income growth. While Artemis Therapeutics,'s Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


INKS's I. Quarter Q/Q Operating Income Comment
Current Operating Loss of -0.02 millions by Artemis Therapeutics, Inc. come out even more unfavourable considering the 0.06 millions in the forth quarter.

Within Biotechnology & Drugs industry Artemis Therapeutics, Inc. achieved highest sequential Operating Income growth. While Artemis Therapeutics,'s Operating Income growth quarter on quarter, overall rank is .


Artemis Therapeutics,'s 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2019)
12 Months Ending
(March 31, 2015)
12 Months Ending
(Dec. 30, 2014)
12 Months Ending
(Sep. 30, 2014)
12 Months Ending
Cumulative Operating Income 12 Months Ending $ 0.45 $ -0.33 $ 0.40 $ 0.37 $ 0.00
Y / Y Operating Income Growth (TTM) -60.83 % - - - -
Year on Year Operating Income Growth Overall Ranking # 1760 # 2021 # 277 # 144 # 142
Seqeuential Operating Income Change (TTM) -41.45 % - 10.68 % -5.68 % -
Seq. Operating Income Growth (TTM) Overall Ranking # 1935 # 2373 # 1681 # 459 # 539




Cumulative Operating Income growth Comment
Artemis Therapeutics, showed decline, but improvement compare to trailing twelve month Operating Income decrease in March 31, 2015. If the fiscal year would end in Mar 31 2019, Artemis Therapeutics,'s annual Operating Income decline would be -60.83% year on year to $0 millions.

In the Healthcare sector 98 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 1760, from total ranking in previous quarter at 2021.

Operating Income TTM Q/Q Growth Statistics
High Average Low
10.68 %
-12.15 %
-41.45 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 14
Healthcare Sector # 99
Overall # 1760

Operating Income TTM Y/Y Growth Statistics
High Average Low
-60.83 %
-60.83 %
-60.83 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 122
S&P 500 # 1935
Cumulative Operating Income growth Comment
Artemis Therapeutics, showed decline, but improvement compare to trailing twelve month Operating Income decrease in March 31, 2015. If the fiscal year would end in Mar 31 2019, Artemis Therapeutics,'s annual Operating Income drop would be -60.83% year on year to $0 millions.

In the Healthcare sector 98 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 1760, from total ranking in previous quarter at 2021.

Operating Income TTM Q/Q Growth Statistics
High Average Low
10.68 %
-12.15 %
-41.45 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 14
Healthcare Sector # 99
Overall # 1760

Operating Income TTM Y/Y Growth Statistics
High Average Low
-60.83 %
-60.83 %
-60.83 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 122
S&P 500 # 1935




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
INKS's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for INKS's Competitors
Operating Income Growth for Artemis Therapeutics,'s Suppliers
Operating Income Growth for INKS's Customers

You may also want to know
INKS's Annual Growth Rates INKS's Profitability Ratios INKS's Asset Turnover Ratio INKS's Dividend Growth
INKS's Roe INKS's Valuation Ratios INKS's Financial Strength Ratios INKS's Dividend Payout Ratio
INKS's Roa INKS's Inventory Turnover Ratio INKS's Growth Rates INKS's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending Mar 31 2019 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2019
National Healthcare Corp -0.62 %$ -0.623 millions
Lifevantage Corp -2.48 %$ -2.480 millions
Atrion Corp -2.89 %$ -2.895 millions
Electromed, Inc. -4.81 %$ -4.811 millions
Quest Diagnostics Inc -8.82 %$ -8.824 millions
Intuitive Surgical Inc -8.85 %$ -8.854 millions
Corcept Therapeutics Inc -9.71 %$ -9.712 millions
Catalent, Inc. -9.99 %$ -9.986 millions
Stryker Corp -10.66 %$ -10.660 millions
Community Health Systems Inc -10.85 %$ -10.849 millions
Baxter International Inc -11.11 %$ -11.111 millions
Chemed Corp -12.28 %$ -12.279 millions
Diffusion Pharmaceuticals Inc. -12.91 %$ -12.907 millions
Phibro Animal Health Corp -14.81 %$ -14.812 millions
Regeneron Pharmaceuticals Inc -15.38 %$ -15.378 millions
Henry Schein Inc -16.35 %$ -16.348 millions
Davita Inc. -17.09 %$ -17.088 millions
Pacific Health Care Organization Inc -21.30 %$ -21.296 millions
Mednax, Inc. -24.88 %$ -24.875 millions
Becton Dickinson & Co -25.68 %$ -25.683 millions
Exelixis, Inc. -27.30 %$ -27.297 millions
Msa Safety Inc -27.62 %$ -27.625 millions
Tenet Healthcare Corp -28.24 %$ -28.240 millions
Jrsis Health Care Corp -28.94 %$ -28.944 millions
Molecular Templates, Inc. -29.99 %$ -29.995 millions
Ani Pharmaceuticals Inc -32.66 %$ -32.660 millions
Mettler Toledo International Inc -34.04 %$ -34.042 millions
Perrigo Co Plc -34.55 %$ -34.549 millions
American Shared Hospital Services -35.22 %$ -35.220 millions
Foamix Pharmaceuticals Ltd. -38.24 %$ -38.243 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HXN's Profile

Stock Price

HXN's Financials

Business Description

Fundamentals

Charts & Quotes

HXN's News

Suppliers

HXN's Competitors

Customers & Markets

Economic Indicators

HXN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071